Diabetes and brain damage: More (or less) than meets the eye?

Diabetologia

Volumn 49, Issue 10, 2006, Pages 2229-2233

  Ryan, Christopher M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPHY; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM; COGNITION; DIABETES MELLITUS; DISEASE COURSE; ELECTROENCEPHALOGRAM; EYE; HUMAN; MEDICAL RESEARCH; NOTE; PATHOPHYSIOLOGY; PERFUSION; PRIORITY JOURNAL; RETINOPATHY;

BRAIN DISEASES; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; HUMANS;

EID: 33748513643     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0392-3     Document Type: Note

References (41)

1. Auer RN, Wieloch T, Olsson Y, Siesjo BK (1984) The distribution of hypoglycemic brain damage. Acta Neuropathol [Berl] 64:177-191
2. Auer RN, Hugh J, Cosgrove E, Curry B (1989) Neuropathologic findings in three cases of profound hypoglycemia. Clin Neuropathol 8:63-68
3. Chalmers J, Risk MTA, Kean DM, Grant R, Ashworth B, Campbell IW (1991) Severe amnesia after hypoglycemia. Diabetes Care 14:922-925
4. Gold AE, Deary IJ, Frier BM (1993) Recurrent severe hypoglycaemia and cognitive function in type 1 diabetes. Diabet Med 10:503-508
5. Perros P, Deary IJ, Sellar RJ, Best JJK, Frier BM (1997) Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20:1013-1018
6. Wysocki T, Harris MA, Mauras N et al (2003) Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months. Diabetes Care 26:1100-1105
7. Brands AMA, Biessels G-J, De Haan EHF, Kappelle LJ, Kessels RPC (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726-735
8. Musen G, Lyoo IK, Sparks CR, Weinger K et al (2006) Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55:326-333
9. Auer RN (2004) Hypoglycemic brain damage. Metab Brain Dis 19:169-175
10. Ryan CM, Geckle MO, Orchard TJ (2003) Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 46:940-948
11. Ferguson SC, Blane A, Perros P et al (2003) Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52:149-156
12. Wong TY, Klein R, Sharrett AR, et al (2002) Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke 33:1487-1492
13. Wong TY, Mosley TH, Klein R, et al, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators (2003) Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. Neurology 61:806-811
14. Cooper LS, Wong TY, Klein R et al (2003) Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke 37:82-86
15. Patton N, Aslam T, MacGillivray T, Pattie A, Deary IJ, Dhillon B (2005) Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 206:319-348
16. Wong TY, Klein R, Klein BEK, Tielsch JM, Hubbard L, Nieto FJ (2001) Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol 46:59-80
17. Ikram MK, De Jong FH, Van Dijk EJ et al (2006) Retinal vessel diameters and cerebral small vessel disease: The Rotterdam Scan Study. Brain 129:182-188
18. Wessels AM, Simsek S, Remijnse PL et al (2006) Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. DOI 10.1007/s00125-006-0283-7
19. Suter O-C, Sunthorn T, Kraftsik R et al (2002) Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 33:1986-1992
20. Wessels AM, Rombouts SARB, Simsek S et al (2006) Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes 55:334-340
21. Jennings JR, Muldoon MF, Ryan C et al (2005) Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology 64:1358-1365
22. Schmidt R, Launer LJ, Nilsson L-G et al (2004) Magnetic resonance imaging of the brain in diabetes: The Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 53:687-692
23. Hassing LB, Hofer SM, Nilsson SE et al (2004) Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 33:355-361
24. Elias PK, Elias MF, D'Agostino RB, Cupples LA et al (1997) NIDDM and blood pressure as risk factors for poor cognitive performance. Diabetes Care 20:1388-1395
25. Quirce R, Carril JM, Jiménez-Bonilla JF et al (1997) Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type 1 diabetic patients with no clinical history of cerebrovascular disease. Eur J Nucl Med 24:1507-1513
26. Salem MAK, Matta LF, Tantawy AAG, Hussein M, Gad GI (2002) Single photon emission tomography (SPECT) study of regional cerebral blood flow in normoalbuminuric children and adolescents with type 1 diabetes. Pediatr Diabetes 3:155-162
27. Fülesdi B, Limburg M, Bereczki D et al (1997) Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes 46:1840-1845
28. Kario K, Ishikawa J, Hoshide S et al (2005) Diabetic brain damage in hypertension: role of renin-angiotensin system. Hypertension 45:887-893
29. Mäkimattila S, Malmberg-Cèder K, Häkkinen A-M et al (2004) Brain metabolic alterations in patients with type 1 diabetes- hyperglycemia-induced injury. J Cereb Blood Flow Metab 24:1393-1399
30. Ruitenberg A, Den Heijer T, Bakker SLM et al (2005) Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam Study. Ann Neurol 57:789-794
31. De La Torre JC (2004) Alzheimer's disease is a vasocognopathy: a new term to describe its nature. Neurol Res 26:517-524
32. De La Torre JC (2004) Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3:184-190
33. Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes - systematic overview of prospective observational studies. Diabetologia 48:2460-2469
34. Biessels G-J, Staekenborg S, Brunner E, Scheltens P (2006) Risk of dementia in diabetesmellitus: a systematic review. Lancet Neurol 5:64-74
35. Reske-Nielsen E, Lundbaek K, Rafaelsen OJ (1965) Pathological changes in the central and peripheral nervous system of young long-term diabetics. Diabetologia 1:232-241
36. Meyer JS, Rauch G, Rauch RA, Haque A (2000) Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol Aging 21:161-169
37. Qiu C, Winblad B, Fratiglioni L (2005) The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4:487-499
38. Brands AMA, Kessels RPC, Biessels GJ et al (2006) Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes 55:1800-1806
39. van den Berg E, De Craen AJM, Biessels GJ, Gusselkloo J, Westendorp RGJ (2006) The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study. Diabetologia 49:2015-2023
40. Peterson RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303-308
41. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661-666